Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
ASH 2025 | Updated Data for Ascentage Pharmas Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
GENESIS ELECTRIFIED GV70 TAKES HOME PREMIUM CAR OF THE YEAR
Genesis Electrified GV70 awarded Premium Car of the Year at Scottish Car…
NCCN Celebrates Expanding Access to Cancer Treatment in Africa at 2025 AORTIC Meeting with New NCCN Adaptations for Sub-Saharan Africa
Updated cancer treatment guidelines reflect significant progress in cancer care delivery through…
2026 Kia Sportage Named 2025 TOP SAFETY PICK+ in 2025 IIHS Crash Test Ratings
2026 Kia SPORTAGE earns highest-tier 2025 TOP SAFETY PICK+ (TSP+) rating from…
CORRECTION Micron Announces Participation in Investor Event
BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued…
Updated IOC report shows 86 per cent of all permanent Olympic venues still in use
23 October 2025 - An updated analysis of venues shows that 86 per…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…
CORRECTION — Bitcoin Bancorp Announces FINRA Completion of Corporate Name Change to Bitcoin Bancorp and New Trading Symbol BCBC
LAS VEGAS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In a release issued…